Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
10.29.20
OpGen to Provide Business Update and Financial Results for the Third Quarter 2020
10.28.20
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators
10.15.20
OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020

btn News

See All News

Upcoming Events
11.11.20 at 4:30 PM EST
Q3 2020 OpGen, Inc. Earnings Conference Call MORE

btn Events

See all events